Jun-Seok Seo
Presidente presso CELLTRION HEALTHCARE CO., LTD.
Posizioni attive di Jun-Seok Seo
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CELLTRION HEALTHCARE CO., LTD. | Presidente | - | - |
Celltrion Healthcare Holdings Co., Ltd.
 Celltrion Healthcare Holdings Co., Ltd. Financial ConglomeratesFinance Part of Celltrion Holdings Co., Ltd., Celltrion Healthcare Holdings Co., Ltd. operates as an investment holding South Korean company. The company is based in Inchon, South Korea. The company was founded in 2020. Heon-Young Yoo has been the CEO of the company since 2020. Celltrion Healthcare Holdings Co. was acquired by Celltrion Holdings Co., Ltd. on December 06, 2021. | Direttore/Membro del Consiglio | 31/03/2021 | - |
Storia della carriera di Jun-Seok Seo
Statistiche
Distribuzione geografica
| Corea del Sud | 3 |
Posizioni
| Director/Board Member | 1 |
| Chairman | 1 |
Settori
| Finance | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Celltrion Healthcare Holdings Co., Ltd.
Celltrion Healthcare Holdings Co., Ltd. Financial ConglomeratesFinance Part of Celltrion Holdings Co., Ltd., Celltrion Healthcare Holdings Co., Ltd. operates as an investment holding South Korean company. The company is based in Inchon, South Korea. The company was founded in 2020. Heon-Young Yoo has been the CEO of the company since 2020. Celltrion Healthcare Holdings Co. was acquired by Celltrion Holdings Co., Ltd. on December 06, 2021. | Finance |
Celltrion Healthcare Co., Ltd.
 Celltrion Healthcare Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion Healthcare Co., Ltd. manufactures pharmaceutical products. Its products include infliximab, rituximab, and trastuzumab biosimilars. The company was founded on December 29, 1999 and is headquartered in Incheon, South Korea. | Health Technology |
- Borsa valori
- Insiders
- Jun-Seok Seo
- Esperienza
